Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain Ángeles Castro; Pilar Díaz; Pere Domingo; Cristina García-Yubero; Juan E. Losa-García; Antonio Castro; Neus Vidal-Vilar; Susana Aceituno;

Rivaroxaban and selective serotonin reuptake inhibitors: Bleeding risk resulting from their concomitant use Miguel Ángel Bruni-Montero; José Manuel Caro-Teller; José Antonio Hernández-Ramos; Cristian Rosas-Espinoza; Dolores Canales-Siguero; José Miguel Ferrari-Piquero;

Prevalence and types of drug interactions in hospitalized pediatric patients in Mexico City Edmundo Vázquez-Cornejo; Sandra Ivette Román-García; Olga Morales-Ríos;